ArticlePloS one2025
Candidacidal effect of Moringa stabilized silver nanomaterials reveal disruption of cell wall integrity, efflux pump, vacuole homeostasis and virulence traits in Candida auris.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The emerging pathogen Candida auris: host interactions and disease drivers.Journal of biomedical science · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Candida auris (C. auris) is known as a superbug characterized by its high prevalence of multi-drug resistance, causing outbreaks in healthcare settings and leading to high mortality rates worldwide. Developing novel and efficient measures to combat its spread and mitigate its impact on patient outcomes is pertinent. This study describes a simple and eco-friendly method for synthesizing silver nanocomposites and silver-zinc nanocomposites using leaf extract of the Moringa Oleifera (MO), plant. The synthesized nanocomposite was characterized and confirmed by several techniques like Fourier Transform Infrared Spectroscopy (FTIR), X-ray diffractometry (XRD), Thermogravimetric Analysis (TGA), X-ray Photoelectron Spectroscopy (XPS), Scanning electron microscopy (SEM). Moreover, nanocomposites were observed to display effective action against C. auris. Minimum inhibitory concentration (MIC) of Ag-MO and Ag-Zn-MO nanocomposite was found to be 125 µg/mL and 250 µg/mL respectively. Ag-MO was found to be fungicidal in nature while Ag-Zn-MO was fungistatic at their respective MIC's. Mechanistic insights elucidate changed cell wall composition, impaired efflux activity, dysfunctional vacuole and suppressed biofilm formation. In vivo efficacy was demonstrated via nematode model survival and macrophage mediated killing. Both the nanocomposites enhanced Caenorhabditis elegans survival which was 45% in Ag-MO, 41% in Ag-Zn-MO vs. 30% in untreated and also enhanced macrophage mediated killing of C. auris. The current study highlights the potential application of Moringa synthesized AgNPs and Ag-ZnNPs as promising approach to combat C. auris infections in particular post its biocompatibility studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.